Effect of governor vessel moxibustion (GVM) therapy with mild to moderate psoriasis: A randomized clinical trial.

ABSTRACT:

Background

It was hypothesized that governor vessel moxibustion (GVM) therapy may improve the course of mild to moderate psoriasis (PS) in patients.

Methods

A randomized, controlled clinical trial lasting 40 days was conducted at the Shaanxi Provincial Hospital of Chinese Medicine. Investigators were blinded to patient groupings. Individuals with mild to moderate PS ranging in age from 18 to 70 years were enrolled. GVM therapy was administered one every 10 days for 40 days with 1.5 hours on the governor meridian in the GVM therapy group. The PS area and severity index (PASI) and dermatological life quality index (DLQI) scores were monitored before and after treatment.

Results

There was a significant reduction in the mean PASI score in the GVM therapy group of 0.76 poi

SUBMITTER: Sun D 

PROVIDER: S-EPMC10615393 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature